We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 2 of 4 for:    miksad

Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00813293
Recruitment Status : Active, not recruiting
First Posted : December 23, 2008
Last Update Posted : February 27, 2017
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Onyx Therapeutics, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Rebecca Miksad, MD, MPH, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2017